Lonza poised to mandate banks for specialty chemicals spinoff – sources

Swiss drug contract
manufacturer Lonza is preparing to mandate banks for a
stock market listing of its chemicals unit as it focuses on the
faster-growing pharmaceutical and biotech companies business,
two people close to the matter said.